Funding journey: From research to commercialization

on Thursday 27 January 2022, 11:00-15:00 (EET)

Health Capital Helsinki is arranging an online event together with BioInnovation Institute (BII), based in Denmark, on Thursday 27 January, 11:00-15:00 (EET).

Receiving funding and even finding all the various funding opportunities are far from easy. And what do the funding institutions look for when they explore which early-stage life-science projects to fund?

These questions will be addressed by key players in the Nordic life science ecosystem during an online event with a unique possibility to book 1:1 meetings with the presenters from The Novo Nordisk Foundation, BioInnovation Institute and EIR Ventures.

The Chief Technology Officer and Founder of the biotech start-up Twelve Bio, Stefano Stella, will also share Twelve Bio’s journey towards raising a large Series A investment. His experiences serve as inspiration for others who dream about following an entrepreneurial path in life sciences.

Event recording and materials

Thank you for attending the event! Please find the presentations and the event recording below.

Presentation of Novo Nordisk Foundation
Presentation of BioInnovation Institute
Presentation of EIR Ventures

Recording

Event details

Date: Thursday 27 January,
11.00–15.00 EET (Finnish time)

Content: 2 hours of presentations,
2 hours reserved for 1:1 meetings

The event is free of charge.

Schedule

PART 1: Presentations

11.00-11.15: Welcome and introduction from Juha Paakkola, Director at Health Capital Helsinki

11.15-11.35: Presentation of NNF, Karin Hultman, Scientific Manager, Innovation at the Novo Nordisk Foundation: Novo Nordisk Foundation Innovation Grants

11.35-11.55: Presentation of BII, Giles Dudley, Director at BioInnovation Institute: Bridging the funding gap in the innovation ecosystem

– 5-minutes’ break –

12.00-12.20: Presentation of EIR Ventures, Stephan Christgau, Founding Partner at EIR Ventures: The role of Venture Capital in Commercializing Life Science Innovation

12.20-12.40: Case story from a BII startup: Stefano Stella, Chief Technology Officer and Founder at Twelve Bio

12.40-12.55: Questions

PART 2: 1:1 meetings

13.00-15.00: Participants can pre-book meetings with the presenters

About the organisers

Health Capital Helsinki

Health Capital Helsinki is building the greatest health capital by developing the Helsinki Metropolitan health ecosystem, boosting the growth of innovation-driven startups and helping international investors and corporations find opportunities and partners in Finland. Health Capital Helsinki is your guide to the capital region and Finland.

Health Capital Helsinki is supported by a public alliance of the largest cities, hospital and educational institutions in Finland: Cities of Helsinki and Espoo, HUS Helsinki University Hospital, University of Helsinki, Aalto University, and Helsinki Metropolitan Universities of Applied Sciences Haaga-Helia, Laurea and Metropolia.

The BioInnovation Institute Foundation

The BioInnovation Institute Foundation (BII) is an international non-profit foundation supported by the Novo Nordisk Foundation. BII operates an incubator to accelerate world-class life science innovation that drives the development of new solutions by early-stage life science start-ups for the benefit of people and society.

With continued positive development, The Novo Nordisk Foundation can provide up to EUR 470 (3,5 mia. DKK) to BII over 10 years to support early-stage life science projects and start-ups for the benefit of people and society.

Since the inauguration of BII in November 2018, BII has awarded 35 million euros to 68 high-growth start-up companies.